Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$527.67 +1.48 (+0.28%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Change in Accured Expenses (2009 - 2026)

Updated

Vertex Pharmaceuticals' Change in Accured Expenses was $222.5 million in Q2 2026, up 33.6% from $166.6 million a year earlier and up 215.6% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Change in Accured Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vertex Pharmaceuticals' Change in Accured Expenses was -$38.6 million through Jun 30, 2026; for FY2025, it was -$116.9 million.

  • In earlier years, Change in Accured Expenses was $212.9 million in FY2024 (-50.4%), $429.4 million in FY2023 (-20.8%), $542.5 million in FY2022 (+77.6%) and $305.4 million in FY2021 (+149.9%).
  • Quarterly Change in Accured Expenses has moved between -$664.5 million (Q4 2025) and $485.5 million (Q2 2022) over five years.
  • Compared with a year earlier, Change in Accured Expenses was higher in three of the last six quarters, with growth averaging 7.5%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q3 2022 (growth of 195.3%); the worst was Q1 2025 (a decline of 75.2%).
  • Per Business Quant data, VRTX's Change in Accured Expenses in the three quarters before Q2 2026 was $70.5 million (Q1 2026), -$664.5 million (Q4 2025) and $332.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.96 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 1.20 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 338.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 222.50 Mn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 360.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 222.50 Mn
Mar 31, 2026 70.50 Mn
Dec 31, 2025 -664.50 Mn
Sep 30, 2025 332.90 Mn
Jun 30, 2025 166.60 Mn
Mar 31, 2025 48.10 Mn
Dec 31, 2024 -320.10 Mn
Sep 30, 2024 170.60 Mn
Jun 30, 2024 168.30 Mn
Mar 31, 2024 194.10 Mn
Dec 31, 2023 -356.70 Mn
Sep 30, 2023 368.70 Mn
Jun 30, 2023 276.70 Mn
Mar 31, 2023 140.70 Mn
Dec 31, 2022 -437.80 Mn
Sep 30, 2022 433.20 Mn
Jun 30, 2022 485.50 Mn
Mar 31, 2022 61.60 Mn
Dec 31, 2021 51.20 Mn
Sep 30, 2021 146.70 Mn
API Access

Vertex Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VRTX&period=max&api_key=YOUR_API_KEY